Targeted therapy for AML
Targeted therapy uses drugs that attack specific features of cancer cells, known as molecular targets, to stop the cancer growing and spreading.
Clinical trials are currently testing new drugs that target the gene changes associated with leukaemia. Targeted therapy drugs are often used in combination with chemotherapy. Talk to your doctor about the latest developments and whether they would be suitable for you.
A new type of drug treatment called immunotherapy uses the body’s own immune system to fight cancer. This is more commonly used for ALL, but it may be used in some clinical trials for AML. Ask your doctor if there are any advances that might be relevant for you.
A/Prof John Moore (Conjoint UNSW), Senior Staff Specialist Haematology, Department of Haematology and Bone Marrow Transplant, Kinghorn Cancer Centre, St Vincent’s Hospital; Glynda Blomson, Consumer; Kevin Bloom, Senior Social Worker, Haematology and Bone Marrow Transplant, Royal North Shore Hospital; Sharon Frazer, Consumer; Prof Angela Hong, Radiation Oncologist, Chris O’Brien Lifehouse, and Clinical Professor, The University of Sydney; Yvonne King, 13 11 20 Consultant, Cancer Council NSW; Karen Maddock, Clinical Nurse Consultant – Haematology, Westmead Hospital.
View the Cancer Council NSW editorial policy.